Over the past 12 months, 8 insiders at ARTIVION, INC. filed 64 open-market SEC Form 4 transactions on AORT: 0 purchases worth $0 and 64 sales worth $21.7M. Insiders have been net sellers over this period. The most recent filing was on Jun 11, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 26 | Andrew M GreenSVP, Regulatory and Quality | SELL | 30.0K | $20.71 | $621K |
| Mar 4, 26 | Jean F HollowaySVP, General Counsel | SELL | 9.0K | $38.00 | $341K |
| Mar 3, 26 | Lance A BerryEVP, COO, CFO & Treasurer | SELL | 6.3K | $37.78 | $239K |
| Mar 3, 26 | John E DavisChief Commercial Officer | SELL | 4.6K | $37.78 | $173K |
| Mar 3, 26 | Jean F HollowaySVP, General Counsel | SELL | 3.8K | $37.78 | $145K |
| Mar 3, 26 | Amy HortonVP, Chief Accounting Officer | SELL | 901 | $37.78 | $34K |
| Mar 3, 26 | James P MackinPresident & CEO | SELL | 17.9K | $37.78 | $676K |
| Mar 3, 26 | Marshall S. StantonSVP, Clinical & MD Affair | SELL | 2.1K | $37.78 | $81K |
| Mar 2, 26 | Lance A BerryEVP, COO, CFO & Treasurer | SELL | 5.2K | $38.02 | $197K |
| Mar 2, 26 | John E DavisChief Commercial Officer | SELL | 2.8K | $38.02 | $106K |
| Mar 2, 26 | Jean F HollowaySVP, General Counsel | SELL | 2.2K | $38.02 | $83K |
| Mar 2, 26 | Amy HortonVP, Chief Accounting Officer | SELL | 641 | $38.02 | $24K |
| Mar 2, 26 | James P MackinPresident & CEO | SELL | 14.9K | $38.02 | $567K |
| Mar 2, 26 | Marshall S. StantonSVP, Clinical & MD Affair | SELL | 1.5K | $38.02 | $58K |
| Feb 24, 26 | Lance A BerryEVP, COO, CFO & Treasurer | SELL | 4.5K | $35.69 | $160K |
| Feb 24, 26 | John E DavisChief Commercial Officer | SELL | 2.1K | $35.69 | $74K |
| Feb 24, 26 | Jean F HollowaySVP, General Counsel | SELL | 1.7K | $35.69 | $60K |
| Feb 24, 26 | Amy HortonVP, Chief Accounting Officer | SELL | 830 | $35.69 | $30K |
| Feb 24, 26 | James P MackinPresident & CEO | SELL | 13.9K | $35.69 | $497K |
| Feb 24, 26 | Marshall S. StantonSVP, Clinical & MD Affair | SELL | 1.3K | $35.69 | $45K |
| Feb 23, 26 | Lance A BerryEVP, COO, CFO & Treasurer | SELL | 5.0K | $37.59 | $187K |
| Feb 23, 26 | John E DavisChief Commercial Officer | SELL | 3.8K | $37.59 | $142K |
| Feb 23, 26 | Jean F HollowaySVP, General Counsel | SELL | 3.1K | $37.59 | $116K |
| Feb 23, 26 | Amy HortonVP, Chief Accounting Officer | SELL | 1.7K | $37.59 | $65K |
| Feb 23, 26 | James P MackinPresident & CEO | SELL | 21.0K | $37.59 | $788K |
| Feb 23, 26 | Marshall S. StantonSVP, Clinical & MD Affair | SELL | 2.4K | $37.59 | $91K |
| Dec 15, 25 | John E DavisChief Commercial Officer | SELL | 5.0K | $45.11 | $226K |
| Dec 8, 25 | Amy HortonVP, Chief Accounting Officer | SELL | 4.6K | $44.42 | $203K |
| Dec 3, 25 | Jean F HollowaySVP, General Counsel | SELL | 5.3K | $45.30 | $239K |
| Dec 3, 25 | James P MackinPresident & CEO | SELL | 30.9K | $45.46 | $1.4M |
| Dec 2, 25 | James P MackinPresident & CEO | SELL | 30.9K | $45.56 | $1.4M |
| Nov 21, 25 | Marshall S. StantonSVP, Clinical & MD Affair | SELL | 18.7K | $45.35 | $840K |
| Nov 20, 25 | Marshall S. StantonSVP, Clinical & MD Affair | SELL | 11.9K | $44.32 | $525K |
| Nov 18, 25 | Elizabeth A HoffDirector | SELL | 4.2K | $45.10 | $189K |
| Nov 17, 25 | Amy HortonVP, Chief Accounting Officer | SELL | 6.0K | $45.73 | $274K |
| Nov 17, 25 | John E DavisChief Commercial Officer | SELL | 6.4K | $45.17 | $289K |
| Nov 17, 25 | Jean F HollowaySVP, General Counsel | SELL | 6.4K | $45.17 | $289K |
| Nov 14, 25 | John E DavisChief Commercial Officer | SELL | 6.4K | $44.67 | $286K |
| Nov 14, 25 | Jean F HollowaySVP, General Counsel | SELL | 6.4K | $45.00 | $288K |
| Nov 13, 25 | John E DavisChief Commercial Officer | SELL | 6.6K | $45.86 | $301K |
| Nov 13, 25 | Jean F HollowaySVP, General Counsel | SELL | 5.8K | $45.86 | $264K |
| Nov 13, 25 | Amy HortonVP, Chief Accounting Officer | SELL | 3.5K | $45.86 | $160K |
| Nov 13, 25 | James P MackinPresident & CEO | SELL | 34.2K | $45.86 | $1.6M |
| Nov 13, 25 | Marshall S. StantonSVP, Clinical & MD Affair | SELL | 5.0K | $45.86 | $229K |
| Nov 11, 25 | Jean F HollowaySVP, General Counsel | SELL | 10.0K | $46.18 | $462K |
| Nov 10, 25 | John E DavisChief Commercial Officer | SELL | 3.4K | $44.62 | $151K |
| Nov 10, 25 | Jean F HollowaySVP, General Counsel | SELL | 3.0K | $44.62 | $132K |
| Nov 10, 25 | Amy HortonVP, Chief Accounting Officer | SELL | 1.8K | $44.62 | $80K |
| Nov 10, 25 | James P MackinPresident & CEO | SELL | 17.6K | $44.62 | $784K |
| Nov 10, 25 | Marshall S. StantonSVP, Clinical & MD Affair | SELL | 2.6K | $44.62 | $114K |
Over the past 12 months, insiders at ARTIVION, INC. filed 0 open-market purchases worth $0 and 64 sales worth $21.7M on AORT, which makes them net sellers over the period. The most recent Form 4 was filed on Jun 11, 26.
8 different insiders at ARTIVION, INC. filed open-market SEC Form 4 transactions on AORT over the last 12 months.
InsiderTape plots every AORT insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ARTIVION, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →